StockData
Capricor Therapeutics, Inc. logo

Capricor Therapeutics, Inc. (CAPR) stock

CAPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$8.03−0.38 (-4.52%)

Close on Nov 18, 2026Market cap $466.86MP/E –Yield –

Capricor Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Capricor Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $22.27M, down 11.5% year over year. For fiscal 2025 it was $0, down 100.0% from the year before. The highest annual figure on record is $25.18M in fiscal 2023.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0-100.0%
FY2024Dec 31, 2024$22.27M-11.5%
FY2023Dec 31, 2023$25.18M+886.8%
FY2022Dec 31, 2022$2.55M+941.8%
FY2021Dec 31, 2021$244.90K-21.1%
FY2020Dec 31, 2020$310.25K-69.1%
FY2019Dec 31, 2019$1.01M-39.9%
FY2018Dec 31, 2018$1.67M-37.3%
FY2017Dec 31, 2017$2.67M-33.3%
FY2016Dec 31, 2016$4.00M-27.5%
FY2015Dec 31, 2015$5.52M+15.3%
FY2014Dec 31, 2014$4.79M+851.2%
FY2013Dec 31, 2013$503.23K+157.4%
FY2012Dec 31, 2012$195.50K-85.6%
FY2011Dec 31, 2011$1.35M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024$11.13M-7.9%
Q3 FY2024Sep 30, 2024$2.26M-63.4%
Q2 FY2024Jun 30, 2024$3.97M+1.4%
Q1 FY2024Mar 31, 2024$4.91M+64.3%
Q4 FY2023Dec 31, 2023$12.09M+1159.3%
Q3 FY2023Sep 30, 2023$6.19M+288.7%
Q2 FY2023Jun 30, 2023$3.92M–
Q1 FY2023Mar 31, 2023$2.99M–
Q4 FY2022Dec 31, 2022$959.90K+370.4%
Q3 FY2022Sep 30, 2022$1.59M+3799.4%
Q4 FY2021Dec 31, 2021$0-100.0%
Q3 FY2021Sep 30, 2021$0-100.0%
Q2 FY2021Jun 30, 2021$204.08K+309.3%
Q1 FY2021Mar 31, 2021$40.82K-78.0%
Q4 FY2020Dec 31, 2020$57.83K-74.0%
Q3 FY2020Sep 30, 2020$16.86K-88.1%
Q2 FY2020Jun 30, 2020$49.86K-87.8%
Q1 FY2020Mar 31, 2020$185.69K-19.4%
Q4 FY2019Dec 31, 2019$222.10K-65.7%
Q3 FY2019Sep 30, 2019$142.07K-35.2%
Q2 FY2019Jun 30, 2019$410.35K+1.6%
Q1 FY2019Mar 31, 2019$230.50K-42.4%
Q4 FY2018Dec 31, 2018$648.08K+36.2%
Q3 FY2018Sep 30, 2018$219.25K-30.0%
Q2 FY2018Jun 30, 2018$403.96K-59.5%
Q1 FY2018Mar 31, 2018$400.07K-54.6%
Q4 FY2017Dec 31, 2017$475.80K-47.5%
Q3 FY2017Sep 30, 2017$313.27K-58.1%
Q2 FY2017Jun 30, 2017$996.46K–
Q1 FY2017Mar 31, 2017$880.81K–
Q4 FY2016Dec 31, 2016$906.93K–
Q3 FY2016Sep 30, 2016$746.78K–

More Capricor Therapeutics figures

See a number that looks wrong?